National Association of Testing Authorities, Australia
Scope of Accreditation
Melbourne Health Shared Pathology Service - Royal Melbourne Hospital
Melbourne Health Pathology
Site
Royal Melbourne Hospital
Accreditation No.
2448
Site No.
2441
Date of Accreditation
19 Aug 1988
Contact
Ms Simone Taylor
P: +61 (03) 93428000
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Royal Melbourne Hospital
Anatomical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Pericardial fluid; Sputum; Synovial fluid; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Anus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Skin smears | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin fixed paraffin embedded tissue sections | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin fixed paraffin embedded tissue sections | Detection of antigenic targets - VariousBAP1 antibody immunohistochemistry commenced in April 2020; CD7, Glutamine Synthetase, Liver FABP and TLE1 commenced in October 2020; INSM1 antibody in Nov 2020: REVIEW ALL ABOVE AT NEXT RES |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Formalin fixed paraffin embedded tissue sections | BRAF mutation analysis; EGFR mutation analysis; KRAS mutation analysis; NRAS-BRAF mutation analysis |
Chemical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Alcohol |
| Plasma; Serum | Sulfonylurea | |
| Urine | Amphetamines; Benzodiazepines; Cannabis; Opiates | |
| Chemical pathology - Biogenic amines | Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Dopamine; Noradrenaline |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Tacrolimus |
| Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenytoin (dilantin); Valproate (valproic acid, epilim); Vancomycin | ||
| Plasma; Serum | Flucytosine; Voriconazole | |
| Serum | Lithium | |
| Paracetamol (acetaminophen); Salicylate; Teicoplanin | ||
| Urine | Bisacodyl - Cathartic; Danthron - Cathartic; Phenolphthalein - Cathartic; Rhein - Cathartic | |
| Bendrofluazide; Bumetanide; Chlorothiazide; Chlorthalidone; Clopamide; Cyclopenthiazide; Frusemide; Hydrochlorothiazide; Mefruside; Methyclothiazide; Metolazone; Quinethazone | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Other body fluids | Thyroglobulin |
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); α-Fetoprotein (AFP) | ||
| β2-Microglobulin (B2M) | ||
| Plasma; Serum | Prostate specific antigen (PSA); α-Fetoprotein (AFP) | |
| β2-Microglobulin (B2M) | ||
| Serum | Thyroglobulin | |
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Other body fluids | Cortisol |
| Plasma; Serum | Cortisol; Progesterone; Prolactin | |
| Adrenocorticotropic hormone (ACTH) | ||
| Oestradiol | ||
| Saliva | Cortisol | |
| Serum | Aldosterone; Insulin-like growth factor 1 (IGF-1, somatomedin C); Renin | |
| Growth hormone | ||
| C-peptide; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Parathyroid hormone (PTH); Sex hormone binding globulin (SHBG); Testosterone | ||
| Urine | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | B-type natriuretic peptide (BNP); Creatine kinase MB (CKMB); Troponin |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | α1-Antitrypsin phenotype |
| Serum | Caeruloplasmin; Haptoglobins; α1-Antitrypsin | |
| Urine | Oxalate | |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Plasma | Methaemalbumin | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Protein - Total |
| Other body fluids | Albumin; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - Total; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Protein - Total; Sodium; Triglycerides; Urate; Urea | |
| Osmolality | ||
| Plasma | Ammonia | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Angiotensin converting enzyme (ACE); Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Serum | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Magnesium; Phosphate; Phosphorus; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Blood; Serum | Folate |
| Chemical pathology - Investigation of porphyria | Blood | Uroporphyrinogen decarboxylase |
| Porphobilinogen deaminase; Porphyrin biosynthetic enzymes | ||
| Porphyrins - Total | ||
| Faeces | Porphyrins - Total | |
| Plasma | Porphyrins - Total | |
| Porphyrins - Total | ||
| Urine | Porphobilinogen (PBG) | |
| Porphobilinogen (PBG) | ||
| δ-Aminolevulinic acid (δ-ALA) | ||
| Porphyrins - Total | ||
| Chemical pathology - Iron studies | Blood | Zinc protoporphyrin (ZPP) |
| Plasma; Serum | Iron; Transferrin | |
| Ferritin | ||
| Chemical pathology - Markers of bone metabolism | Plasma | Procollagen type 1 N-terminal propeptide (P1NP); β-Crosslaps |
| Plasma; Serum | Bone-specific alkaline phosphatase - Ostase | |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Other body fluids | pH | |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma; Serum | Homocysteine |
| Chemical pathology - Quantitation of vitamins | Serum | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Other body fluids | Rheumatoid factor |
| Serum | Rheumatoid factor | |
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Oligoclonal bands |
| Other body fluids | Asialo-transferrin | |
| Serum | Cryoglobulins | |
| Protein classes | ||
| Urine | Detection of Bence Jones proteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Body fluids | Human chorionic gonadotropin (hCG) - Quantitative total |
| Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total | |
Cryopreservation Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
Emergency Department
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Haematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Blood; Bone marrow | Iron | |
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa activity - Heparin activity; Anti-thrombin III; D-dimer; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor X; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Platelet aggregation; Protein C and protein S; Thrombin time (TT); Von Willebrand factor (vWF) |
| Haematology - Investigation of haemolysis | Blood | Donath-Landsteiner antibody |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD16; CD19; CD3; CD4; CD56; CD8; Natural killer (NK) cells |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Haemochromatosis; Methylenetetrahydrofolate reductase (MTHFR); Prothrombin variant |
Immunohaematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Antibody neutralisation | ||
| Blood; Plasma | Antibody absorption | |
| Red blood cell phenotyping | ||
| Antibody titration; Other blood group antibodies; Rh | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies; Contamination - Microbiological |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood products | Issue and release of blood and blood products for transfusion |
Immunopathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Tryptase |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-insulin antibodies |
| Serum | Anti-endomysial antibodies (EMA); Anti-intracellular substance antibodies; Anti-skin antibodies; Anti-skin basement membrane antibodies; Anti-skin intracellular antibody | |
| Anti-glutamic acid decarboxylase antibodies (GAD); Anti-islet tyrosine phosphatase2 (IA2) antibodies | ||
| Anti-intrinsic factor antibodies (IF) | ||
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-striated muscle antibodies | ||
| Anti-ribosomal P protein antibodies | ||
| Anti-cardiolipin antibodies (ACA); Anti-deamidated gliadin antibodies; Anti-glomerular basement membrane antibodies (anti-GBM); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Anti-CV2; Anti-Hu; Anti-Ri; Anti-SOX1; Anti-Tr/DNER; Anti-Yo; Anti-Zic4; Anti-amphiphysin; Anti-glutamic acid decarboxylase 65 (GAD65); Anti-neuronal antibodies; Anti-paraneoplastic Ma2 (PNMa2); Anti-recoverin; Anti-titin | ||
| Anti-nuclear antibodies (ANA) | ||
| Anti-acetylcholine receptor antibodies (AChR); Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-adrenal cortex antibodies | ||
| Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-smooth muscle antibodies (SMA) | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA) | ||
| Anti-histone antibodies (AHA) | ||
| Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO); Anti-thyrotropin receptor antibodies (TSHR) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Cefaclor; Chlorhexidine; Morphine; Penicilloyl G; Penicilloyl V; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Cat dander; Cat epithelium; Cow dander; Dog dander; Horse dander |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Blue mussel; Codfish; Crab; Crayfish; Lobster; Oyster; Salmon; Seafood mix; Shrimp; Squid; Trout; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Avocado; Banana; Kiwi; Mango |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Omega-5-gliadin; Staple food mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Brazil nut; Cashew nut; Gluten; Hazelnut; Macadamia nut; Nut panel; Peanut; Pecan nut; Pinenut; Pistachio; Sesame seed; Soy bean; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Grass mix; Rye grass; Timothy grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | German cockroach |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Anisakis; Aspergillus fumigatus; Cladosporium herbarum; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; House dust mite mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Formaldehyde/formalin; House dust; Latex; Oxirane (ethyleneoxide) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Australian pine; Recombinant birch; Recombinant birch profilin; Silver birch; Tree mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Honey bee venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Ribwort; Weed mix |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin E |
Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Sputum; Synovial fluid; Tissues; Urine | Antibiotic susceptibility; Bacteria; Pathogenic microorganisms |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Sputum; Synovial fluid; Tissues; Urine; Wound swabs | Bacteria; Pathogenic identification; Pathogenic microorganisms | |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Sputum; Tissues; Urine; Wound swabs | Bacteria; Pathogenic identification; Pathogenic microorganisms | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Sputum; Synovial fluid; Tissues; Urine; Wound swabs | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Urine | Blood; Erythrocytes (red blood cells, RBC); Glucose; Leucocytes (white blood cells, WBC); Proteins; Specific gravity; pH | |
| Blood; Glucose; Proteins; Specific gravity; pH | ||
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Microbiology - Environmental investigations and/or infection control | Air | Bacterial growth - Sterility |
| Blood transfusion bags; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility | |
| Environmental swabs | Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Methicillin resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Multi-drug resistant organisms (MDR); Bacterial organism identification - Vancomycin resistant Enterococcus (VRE); Carbapenemase-producing organisms (CPO); Yeast organism identification - Candida auris | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Blood | Acinetobacter baumannii; Enterobacter cloacae complex; Enterobacteriaceae; Enterococcus spp.; Escherichia coli; Haemophilus influenzae; Klebsiella oxytoca; Klebsiella pneumoniae; Klebsiella pneumoniae carbapenemase (KPC); Listeria monocytogenes; Neisseria meningitidis - Encapsulated; Proteus spp.; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus; Staphylococcus spp.; Streptococcus agalactiae (Streptococcus group B); Streptococcus pneumoniae; Streptococcus pyogenes; Streptococcus spp.; MecA gene; Van A/B |
| Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs | Bordetella bronchiseptica; Bordetella holmesii; Bordetella parapertussis; Bordetella pertussis; Chlamydophila pneumoniae; Legionella longbeachae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Cerebrospinal fluid (CSF) | Escherichia coli K1; Haemophilus influenzae; Listeria monocytogenes; Neisseria meningitidis - Encapsulated; Streptococcus agalactiae (Streptococcus group B); Streptococcus pneumoniae | |
| Dry swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Faeces | Campylobacter coli; Campylobacter jejuni; Campylobacter upsaliensis; Clostridioides difficile toxin; Escherichia coli - Enteroaggregative (EAEC); Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Enteropathogenic (EPEC); Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli STEC stx1/stx2; Plesiomonas shigelloides; Salmonella spp.; Shigella spp.; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio vulnificus; Yersinia enterocolitica | |
| Clostridiodes difficile; Vancomycin resistant Enterococci (VRE) | ||
| Nasopharyngeal swabs | Bordetella pertussis; Chlamydophila pneumoniae; Mycoplasma pneumoniae; Respiratory pathogens | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Blood culture | Candida albicans; Candida glabrata; Candida krusei; Candida parapsilosis; Candida tropicalis |
| Cerebrospinal fluid (CSF) | Cryptococcus gattii; Cryptococcus neoformans | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Sputum | Mycobacterium tuberculosis complex; Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium spp.; Cyclospora cayetanensis; Entamoeba histolytica; Giardia lamblia |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood; Bronchial washings; Bronchoalveolar lavage; Dry swabs; Respiratory specimens; Sputum | Adenovirus; Cytomegalovirus (CMV); Enterovirus; Human herpes virus type 1/2 (HHV1/2); Varicella zoster virus (VZV) |
| Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs | Adenovirus; Coxsackie virus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Influenza virus H1N1 - Swine; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus | |
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | ||
| Cerebrospinal fluid (CSF) | Cytomegalovirus (CMV); Enterovirus; Human herpes virus type 6 (HHV6); Human herpes virus type 1/2 (HHV1/2); Human parechovirus; Varicella zoster virus (VZV) | |
| Endotrachael aspirate | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | |
| Faeces | Norovirus | |
| Adenovirus F40; Adenovirus F41; Astrovirus; Norovirus G1; Norovirus G2; Rotavirus A; Sapovirus I; Sapovirus II; Sapovirus IV; Sapovirus V | ||
| Nasal aspirates/washes; Nasopharyngeal swabs; Oropharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | |
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | |
| Adenovirus; Enterovirus; Human coronavirus NL63; Human coronavirus 229E; Human coronavirus HKU1; Human coronavirus OC43; Human metapneumovirus; Influenza A virus; Influenza A virus H1; Influenza A virus H1 - 2009 pandemic strain; Influenza A virus H3; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus; Respiratory pathogens | ||
| Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | ||
| Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | ||
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma | Hepatitis B virus (HBV) viral load; Human immunodeficiency virus (HIV) RNA viral load |
| Serum | BK viral load | |
| Cytomegalovirus (CMV) viral load; Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load; Human immunodeficiency virus (HIV) RNA viral load | ||
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Blood; Cerebrospinal fluid (CSF); Faeces; General swabs; Other body fluids; Respiratory specimens; Sputum; Tissues; Urine | Mycobacteria identification |
| Mycobacteria identification | ||
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elements | Cerebrospinal fluid (CSF) | Cryptococcus antigen |
| Fluids; General swabs; Hair; Nails; Skin scrapings; Sputum; Tissues | Yeast susceptibility | |
| Fluids; General swabs; Hair; Nails; Skin scrapings; Tissues | Fungi identification | |
| Hair; Nails; Respiratory swabs; Skin scrapings; Sputum; Tissues | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Strongyloides stercoralis |
| Microsporidia | ||
| Cryptosporidia; Cyclospora | ||
| Cysts; Ova; Parasites | ||
| Cryptosporidia; Entamoeba histolytica; Giardia spp. | ||
| Urine | Schistosoma spp. | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma | Dengue virus |
| Cerebrospinal fluid (CSF); Serum | Syphilis Treponema pallidum antibody | |
| Syphilis Treponema pallidum antibody | ||
| Faeces | Helicobacter pylori | |
| Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody | ||
| Serum | Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus IgG antibody; Epstein-Barr virus IgM antibody; Epstein-Barr virus nuclear antigen; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody | |
| Hepatitis C virus antibody (anti-HCV); Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Mumps virus IgG antibody; Varicella zoster virus IgG antibody | ||
| Helicobacter pylori | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Adenovirus; Rotavirus |
Molecular Genetics
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Kennedy's disease (spinal and bulbar muscular atrophy) |
| Molecular genetics - Bioinformatic analysis | DNA sequences | Tertiary analysis - Data annotation and interpretation |
| Molecular genetics - DNA extraction | Blood | Viable DNA; Viable DNA for sequencing |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | Kennedy's disease (spinal and bulbar muscular atrophy) |
Operating Theatre
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
PC3 Facility
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Chloride; Creatinine; Glucose; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Troponin; pH |
| Haematology - Full blood examination | Blood | Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC); Platelet count |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Thermoelastography - R, K, Angle, Ma, LY30 |
| Activated partial thromboplastin time (APTT); International normalised ratio (INR); Prothrombin time (PT) |
Ward 6SE
ISO 15189 (2012)
Human Pathology
Medicare expiry date
22 Jun 2024
Last Activity Date
31 Jan 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Deoxyhaemoglobin (HHb); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2448
Site No.
2441
Print date
17 Sep 2021
END OF SCOPE